It's used for patients whose natural GH production has declined with age, typically presenting as increased body fat, reduced lean muscle, poor sleep, and low energy
Clinical epidemiology of cardiovascular disease in chronic renal disease
[DOI] [PMC free article] [PubMed] [Google Scholar] 191.Zhou M, et al
It gives Novo Nordisk an opportunity to remain competitive on efficacy while it continues developing next-generation therapies. Other drugs have already shown greater efficacy in prior studies, and the broader GLP-1 space is likely to see much more significant change as new molecules enter the market. Balazs called the higher dosage a major jump, noting that the incidences of stomach- and skin-related side effects at this higher dose are meaningful. CLICK HERE FOR MORE HEALTH STORIES This approval is for obesity management, not diabetes treatment, the expert emphasized
Ultimately, the duration of GLP-1RA treatment seems to be the factor that explains the heterogeneity of the clinical studies involving GLP-1RA
Carewell Herbs is one of Trade India's verified and trusted sellers of listed products